IngredientesDeer antler velvet (DAV) is harvested from the growing antlers of deer, a biologically dynamic animal-derived material that has attracted scientific interest due to its regenerative characteristics and complex biochemical composition. A velvet antler is covered in a hairy, soft "skin" known as velvet, with the developing antler having rounded tines during its annual growth and remaining uncalcified. Antler velvet is typically harvested from farmed deer or elk before the antlers fully calcify, during the annual process that occurs when the antler is still in its soft, cartilaginous stage, usually between 45 to 65 days of growth.
Most of the world's supply of velvet antler comes from Sika deer (Cervus nippon), red deer (Cervus elaphus), and elk (also called wapiti), including a large deer ranching industry in New Zealand. In Oriental classification, animals for the traditional use of antlers are limited only to sika deer (Cervus nippon), red deer (Cervus elaphus), and elk (Cervus canadensis). In Traditional Chinese Medicine, the substance is known as lu rong (鹿茸). New Zealand is the world's largest producer of velvet. Australia, China, Russia, the United States, and Canada also produce velvet antler products for the supplement market.
In Asia, velvet antler is dried and sold as slices, or as a powder which may be boiled in water, usually with other herbs and ingredients, and consumed as a soup. A 16th-century medical text, Pen Ts'ao Kang Mu, lists several antler preparations including pills, tinctures, and ointments. Early commercial activity in Russia between the 1930s and 1980s led to the production of an alcohol extract from deer antler velvet marketed under the Russian drug trade name Pantocrin (also pantocrine or pantokrin).
In the traditional commercial trade of Korea and China, whole-stick antler velvet is divided into three sections based upon their supposed properties. Although there is an absence of uniform standardization, these sections are known as the wax piece (uppers or tips), the blood piece (middles), and the bone piece (bottoms): the wax piece may be marketed as a growth tonic for children, the blood piece supposedly for joint and bone effects, and the bone piece supposedly for calcium deficiency and geriatric needs.
Modern commercial forms include encapsulated powders, liquid extracts, sublingual sprays, and standardized tablets. In New Zealand, deer are subjected to local anesthesia and restrained during antler removal, and the procedure is supervised by licensed veterinarians.
The first documented evidence of deer velvet as a medicinal was found on a scroll recovered from a tomb in Hunan, China, dating back 2,000 years. The use of antler dates back to the Han Dynasty, 206 BC to 220 AD. In traditional Chinese medicine, velvet antler has been used for over 2,000 years as a tonic, to improve bone health, to nourish the blood, reduce swelling, and to treat impotence.
Deer products like velvet antlers or VA blood are classified as kidney yang-tonifying and replenishing medicines in Bencao Gangmu (Compendium of Materia Medica), a famous TCM classic written by Li Shi-Zhen about 500 years ago. Therapeutically, both VA and VA blood tonify qi, essence, and marrow, nourish the blood, and invigorate bones and tendons.
Koreans use antler velvet to treat anemia and impotence and to stimulate the immune system, improve heart function, muscle tone, lung efficiency, and nerve function. In the 1960s, an injectable form of deer velvet was used by Japanese physicians to treat male sexual dysfunction. In traditional Oriental medicine, elk velvet antler is still one of the most frequently prescribed animal-derived ingredients.
Later research on deer antler dates back to the 1980s in Russia. Hundreds of articles since have been published including those documented by Chinese, Korean, and Japanese scientists. Pantocrin has been prescribed internally in doses of 25–40 drops or 1–2 tablets twice daily, taken 30 minutes before eating. Typical courses of treatment last from two to three weeks; however, three courses are given with a seven- to ten-day break between courses.
According to an ancient medical document of Korea, antlers are disclosed to have energy restoration, a blood nourishing action, pain alleviation, hemopoiesis, growth promotion, heart failure remediation, and hyperfunction. In herbal combinations, deer velvet is used to improve athletic performance; to improve eyesight and hearing; to reduce stress; and to treat arthritis, osteoporosis, "tired blood" (anemia), women's reproductive disorders including premenstrual syndrome (PMS), erectile dysfunction, and skin conditions.
DAV contains proteins, peptides, growth-associated factors, polysaccharides, amino acids, lipids, and minerals, which have been investigated across diverse experimental systems. Major categories of bioactive components present in DAV include proteins and peptides, growth factors (IGF-1, EGF, TGF-β, FGFs), collagen and glycosaminoglycans, amino acids and minerals (essential and non-essential amino acids, Ca, P, Mg, Zn, Fe), lipids, phospholipids and gangliosides, and polysaccharides and other small bioactive molecules (nucleotides, sialic acid, vitamins).
Proteins form a major structural and functional component of DAV, accounting for a significant portion of its dry weight. Collagen, particularly type I and type II, is the most abundant protein and contributes to tissue strength, elasticity, and regenerative capacity.
Insulin-like growth factor-1 (IGF-1) is particularly notable for promoting skeletal growth, muscle repair, and cartilage regeneration. Epidermal growth factor (EGF) and transforming growth factor-beta (TGF-β) stimulate cellular proliferation and extracellular matrix production, enhancing tissue repair. Fibroblast growth factors (FGFs) in DAV contribute to angiogenesis and wound healing. The presence of these growth factors provides mechanistic plausibility for reported regenerative and osteogenic effects observed in experimental systems.
Therapeutic effects are attributed to several bioactive compounds, including glycosaminoglycans, uronic acids, sialic acid, phospholipids, oestrogens, and notably a range of growth factors such as insulin-like growth factor-1 (IGF-1), nerve growth factor, and epidermal growth factor. Deer antler velvet is a natural source of glucosamine, chondroitin, and collagen. The body uses glucosamine to manufacture glycosaminoglycans that are found in cartilage tissue. Glycosaminoglycans (GAGs), also known as mucopolysaccharides, form an important component of connective tissues.
Polysaccharides in DAV, including both neutral and acidic types, exhibit strong immunomodulatory and antioxidant activities, stimulating immune cell activity and reducing oxidative stress. The combination of lipids and gangliosides enhances the multifunctional bioactivity of DAV, particularly in brain health and anti-aging interventions. DAV also contains nucleotides, sialic acid, vitamins, and other small molecules that further contribute to its pharmacological properties.
The chemical composition of velvet antler undergoes dynamic changes depending on its growth stage and seasonal variations. As the antler growth cycle progresses, overall yield increases. However, the levels of bioactive compounds such as proteins, total amino acids, glycosaminoglycans, uronic acid, and sialic acid tend to decrease, while the content of ash and collagen increases. These changes suggest that prolonged growth periods may lead to a reduction in biologically active substances, potentially affecting the overall quality of the antler.
These constituents collectively contribute to the regenerative, immunomodulatory, antioxidant, and therapeutic properties of DAV.
Antioxidant pathways: The antioxidant properties of velvet antler are attributed to a variety of chemical constituents (such as peptides, phospholipids, fatty acids, and other compounds) and multiple biological pathways (including Nrf2/HO‐1, EGF/EGFR, and NF‐κB). These mechanisms collectively contribute to the attenuation of oxidative injury through multiple processes, including neutralization of reactive species, reinforcement of endogenous antioxidant enzyme systems, and regulation of redox-related signaling pathways.
Anti-inflammatory pathways: Beyond amino acids and peptides, proteins and polysaccharides are also critical bioactive macromolecular components in velvet antler. Studies have revealed that velvet antler contains various proteins such as collagen, serum transferrin, and apolipoprotein, and related extracts are associated with biological effects including anti-inflammatory, antioxidant, and hepatoprotective activities in vitro and in animal models.
IGF-1 and hormonal signaling: IGF-1 is an anabolic molecule which appears to induce growth of the antlers themselves, although testosterone may be the primary growth factor. Currently, there is no evidence that serum IGF-1 is increased following velvet antler ingestion, with one study using 1.5 g of velvet antler for 11 weeks failing to increase serum IGF-1.
Hematopoietic and immune effects: Myelosuppression is one of the most common chemotherapy side effects. Studies have shown that velvet antler polypeptides (VAPs) could enhance immunity and anti-aging and also have a hematopoietic-promoting effect. However, there are relatively few studies on the treatment of myelosuppression with VAPs, and the therapeutic mechanism remains unclear.
Although numerous studies report immunomodulatory, antioxidant, regenerative, neuroprotective, and musculoskeletal-related effects, the strength of evidence varies considerably, with the majority of data derived from in vitro and animal models and comparatively limited well-controlled human trials.
The key clinical systematic review in this field was conducted by Gilbey and Perezgonzalez (2012), published in the New Zealand Medical Journal. The aim of this systematic review was to evaluate the evidence from RCTs of velvet antler supplements for any condition, using the QUOROM statement as a guiding framework. Four electronic databases (PubMed, Medline, Web of Science, and Academic Search Premier) and two review articles were searched for all randomised clinical trials of velvet antler supplements. Seven RCTs were identified as satisfying all inclusion criteria and examined the effectiveness of velvet antler for rheumatoid arthritis (2), osteoarthritis (1), sexual function (1), and sporting performance enhancement (3). Their methodological quality ranged from 3–5, as measured on the Jadad scale. Two RCTs reported some positive effects of velvet antler supplements, but neither were convincing while the remaining five RCTs found no effect of velvet antler supplements.
All except one of the included RCTs were underpowered and therefore the possibility of type II error cannot be ruled out.
Two RCTs examined velvet antler for rheumatoid arthritis. The phase II trial by Allen et al. (2002) enrolled 40 patients with stage II rheumatoid arthritis. Forty patients with stage II rheumatoid arthritis were randomly assigned to one of four arms. One group received placebo and the other three groups received 2, 4, or 6 capsules (215 mg) of elk velvet antler with appropriate placebos to total 6 capsules daily. All subjects continued to take their arthritis medications. At one month, there were no significant differences between groups in number of adverse events or health status. The greatest improvement was in the 6 elk velvet antler group, the least was in the placebo group. Differences were not statistically significant. It was concluded that elk velvet antler can be taken safely in conjunction with a number of rheumatoid arthritis medications and should be studied further to assess efficacy.
The larger follow-up RCT (Allen et al. 2008) enrolled 168 patients. This trial examines the effects of elk velvet antler on joint pain and swelling, patient/physician global assessment of disease activity, functional ability, quality of life, blood levels of C-reactive protein, and adverse events in persons with stage 2 to 3 rheumatoid arthritis experiencing residual symptoms after standard treatment. Patients (N=168) were enrolled in a 6-month randomized, triple-blind, placebo-controlled clinical trial. Instruments included the Arthritis Impact Measurement Scale, the Health Assessment Questionnaire, tender and swollen joint counts, and 100 mm-length visual analogue scales, along with blood tests. There were no significant differences between groups on any measures. The pattern of change of the measures across time points was essentially the same for both groups. Although some patients reported clinical improvements in their symptoms, there were no statistically significant differences between groups. Overall, elk velvet antler does not effectively manage residual symptoms in patients with rheumatoid arthritis.
Evidence strength: Claims made for velvet antler supplements do not appear to be based upon rigorous research from human trials, although for osteoarthritis the findings may have some promise. Evidence for rheumatoid arthritis is currently negative based on the available controlled human trials.
One RCT identified in the 2012 systematic review examined osteoarthritis outcomes, with the review concluding there was modest, non-definitive promise in that indication. Science has validated the use of glucosamine sulfate as a treatment for osteoarthritis, and both chondroitin and collagen show promise in arthritis treatment. The presence of these compounds may explain the effects of deer antler velvet on joint tissue.
At the preclinical level, antler preparations have been examined in animal models for osteoporosis. The anti-osteoporotic activity of velvet antler middle sections combined with velvet antler blood was evaluated with ovariectomized (OVX) rats at a dose of 0.2 g/kg. In treated OVX rats, body weight decreased 10.7%, and the strength of vertebrae and the femur respectively increased 18.1% and 15.4%, compared to the control. Treatment also recovered the estrogen-related loss of the right tibial trabecular bone microarchitecture. These are animal data only; equivalent controlled human trials are lacking.
Evidence strength: Preliminary; predominantly animal and in vitro data, with one weakly positive human RCT for osteoarthritis and no confirmed human trials for osteoporosis.
Three RCTs examined velvet antler for sporting performance. Early research suggests that taking deer velvet extract or powder by mouth for 10 weeks does not improve strength or aerobic capacity in active males undergoing strength training. However, there may be small improvements in knee extension strength.
Repeated studies have been conducted on the interactions of velvet antler and hormones, and all studies have found that this supplement has failed to increase circulating hormone levels. One study found a highly variable increase in power output, which is antagonized by another study suggesting no significant increase in power.
For the purposes of performance enhancement, the evidence does not currently support velvet antler as a supplement.
Evidence strength: Weak and inconsistent; the majority of RCTs show no significant benefit for aerobic power, muscle strength, or endurance.
One blinded study in 34 otherwise healthy men given 1 g powdered velvet antler daily for 12 weeks failed to exert any erectile benefit (measured by IIEF) and did not alter self-reported orgasm or sexual satisfaction. This study also failed to find any significant difference in aphrodisia as assessed by the BISF-W rating scale. Currently there is no evidence to support an increase in aphrodisia, although only one trial has been conducted.
Early research suggests that taking deer velvet powder by mouth for 12 weeks does not improve sexual function or desire in people in stable relationships.
At the animal level, twenty-four-month-old male C57BL/6 mice with low serum testosterone levels were used as a late-onset hypogonadism (LOH) animal model for examining the effects of velvet antler polypeptide (VAP) on sexual function and testosterone synthesis. These mice received VAP for 5 consecutive weeks by daily gavage at doses of 100, 200, or 300 mg kg⁻¹ body weight per day. The authors concluded that further clinical trials and safety assessments in humans still need to be performed.
Evidence strength: The sole human RCT found no benefit. Animal studies are preliminary and cannot be extrapolated to humans.
Velvet antler from the sika deer is used in traditional Chinese medicine and modern nutraceuticals for its benefits in treating chronic diseases and providing tonic effects. These benefits are due to its antioxidant capabilities, anti-inflammatory effects, anti-osteoporosis properties, and tissue repair functions. Velvet antler methanol extracts have protective properties against oxidative stress and can alleviate symptoms in Parkinson's disease models. These findings remain at the experimental (animal/cell) stage.
Certain antioxidant peptides display other bioactivities, such as antihypertensive and neuroprotective effects. Despite these advances, the current understanding remains incomplete.
Evidence strength: Preclinical only; no adequate human RCTs exist for these indications as of the available literature.
Pharmacological research on antler velvet has uncovered a rich array of physiologically active elements, including growth factors, hormones, minerals, and proteins. This composition suggests a range of potential physiological impacts, with research primarily focusing on anti-inflammatory, antioxidant, promotion of skeletal development, immune enhancement, and energy-boosting effects.
Ongoing studies are now seeking to discern the potential positive effects of antler velvet on blood circulation, vasodilation, and blood pressure regulation.
Evidence strength: Predominantly in vitro and animal data; clinical human evidence is absent.
Velvet antler contains an abundance of bioactive compounds including amino acids, peptides, proteins, and nucleosides. It exhibits notable health-promoting properties such as wound repair, antioxidant activity, and metabolic regulation, making it a high-quality natural ingredient for functional foods and biopharmaceutical applications.
There is preliminary evidence for other possible benefits of velvet antler, and this supplement may potentially have a role in fracture/bone healing rates, anti-addictive properties, and improving skin regeneration rates pending more research; all three topics show some promise right now.
Evidence strength: Preliminary; primarily derived from cell-based and animal studies, with limited clinical translation.
Typical dosage ranges from 400 to 600 mg/d, but higher dosages of 900 to 2,400 mg/d are recommended in certain deer velvet antler-containing products. Pantocrin tablets contain 1% of extract. Pantocrin has been prescribed internally in doses of 25–40 drops or 1–2 tablets twice daily, taken 30 minutes before eating.
In clinical research, the following dosages have been specifically reported:
Two possible options exist per Examine.com's summary: 500 mg once daily, which is what seems to be used in most dietary supplements; and 1,000–2,000 mg daily, which appears to be the recommendation from traditional Chinese medicine. Due to a lack of human evidence to support benefits of this supplement, an optimal dosage cannot yet be ascertained.
Based on long-term clinical use, velvet antler and its extracts are generally considered safe, with no major adverse effects reported to date. Given its high chondroitin content, side effects may include epigastric pain, nausea, diarrhea, constipation, eyelid edema, and allergic reactions.
Velvet antler is susceptible to contamination by exogenous substances during farming, processing, and storage. According to the Chinese Pharmacopoeia, animal-derived medicines are characterized by complex compositions, perishability, and vulnerability to contamination by heavy metals, pesticide residues, and veterinary drug residues. Although the ChP requires testing for heavy metals such as lead, cadmium, arsenic, mercury, and copper, specific limits for heavy metals in animal-derived medicines are not as strictly defined as for botanical drugs.
Xylazine, used as an anesthetic for antler harvesting, has been found in freshly harvested velvet antler. Xylazine, a veterinary anesthetic often found in street fentanyl in the twenty-first century, is highly sedative and carcinogenic. Studies have found that low but potentially dangerous levels of xylazine are contained in deer antler products.
Proper extraction and processing influence the safety profile of DAV. The presence of residual solvents, microbial contamination, or improperly processed growth factors could pose health risks.
Recurring contact with deer products has been associated with severe allergic rhinitis and a pruritic dermal reaction in farmers. Allergic rhinitis and asthma also have occurred as a result of cross-reactivity with extracts from other mammals, and may arise because of animal dander exposure.
Because of potentially increased testosterone levels, deer velvet antler is also contraindicated in patients with a history of prostate cancer.
The presence of prions in elk velvet adds risk for human exposure to the disease. This theoretical risk, relating to chronic wasting disease (CWD) documented in cervid populations in North America, has been noted in veterinary and safety literature, though confirmed human cases have not been established in the literature reviewed.
Although no toxic or teratogenic effects were observed when pantocrin was given to pregnant rats and mice, there was a 50% reduction in the number of implantation sites and a subsequent reduction in the number of live fetuses at a high dosage level of 6 mL/kg. These are animal-level findings; human reproductive safety data is absent.
Following inquiries regarding the supplement Deer Antler Spray, WADA issued the following statement: Insulin-Like Growth Factor-1 (IGF-1) is prohibited under S2.4 of the List of Prohibited Substances and Methods. Deer Antler Velvet Spray may contain IGF-1 and WADA recommends therefore that athletes be extremely vigilant with this supplement because it could lead to a positive test. There can be no guarantee that IGF-1 taken orally will not influence the plasma level of IGF-1, which may then influence the result of anti-doping tests.
Deer antler velvet is not on the DoD Prohibited Dietary Supplement Ingredients List, but products containing IGF-1 are prohibited for use. Without laboratory testing there is no way to know for certain whether dietary supplements that list deer antler velvet among their ingredients do or do not contain IGF-1.
Challenges remain in species authentication, mechanistic understanding of active constituents, and quality standardization, which impede the modern development and efficient utilization of this resource. No accepted formulations of deer velvet antler exist.
Rather than expanding the range of proposed indications, strengthening the depth of mechanistic validation and clinical evidence will determine the realistic scope of DAV integration into functional foods, dietary supplements, and regenerative biomedical strategies. A systematic, evidence-driven approach will be critical to define its role within modern health science.
Velvet antler appears to be safe, but ineffective at the most commonly touted claims. The current body of human clinical evidence is limited, predominantly underpowered, and has so far failed to support the most prominent marketing claims for athletic performance, sexual function, or rheumatoid arthritis. Some preliminary signals exist for osteoarthritis. A large body of preclinical (animal and in vitro) evidence supports biological plausibility for antioxidant, anti-inflammatory, regenerative, and immunomodulatory properties, but these have not been adequately translated into confirmed human clinical outcomes.
Condiciones de salud que cornamenta puede ayudar a apoyar.
Antler (calcified or velvet deer/elk antler, 'lu rong' or 'lu jiao') is used in TCM and Korean medicine for millennia as a Kidney-Yang tonic for male impotence, infertility, and sexual debility. It contains growth factors, androgens, and amino acids.
Sistemas corporales que cornamenta puede ayudar a apoyar.
Volver